Antibacterials to treat resistant pathogens could be approved based on limited phase III study data,
KeywordsDevelopment Programme Limited Range Great Benefit Study Data Drug Product
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Adis International Ltd 2002